Veritas In Silico Inc.
@veritasinsilico.com
Veritas In Silico is unveiling the mysteries of RNA and harnessing the potential of messenger RNA (mRNA) as a drug target. Powered by our proprietary in silico technology, we have established an entirely new system for drug discovery that focuses on finding drugs against structural motifs on mRNA. The discovery of drugs that target mRNA is a promising direction for drug development and a new paradigm for the pharmaceutical industry. It has the potential for application to any disease, including those for which conventional protein-targeted discovery has not yielded effective treatments. Veritas In Silico’s mission is to build a society where every patient, especially those with diseases that currently have no satisfactory treatment, can look forward to a brighter future through the realization of mRNA-targeted drugs.
Veritas In Silico Inc.'s Company Logos
Veritas In Silico Inc.'s Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#B41E1E
Roof Terracotta
180, 30, 30
0, 71, 41
0, 83, 83, 29
#90E0F2
Spray
144, 224, 242
191, 79, 76
40, 7, 0, 5
#BD1D1D
Thunderbird
189, 29, 29
0, 73, 43
0, 85, 85, 26
About Veritas In Silico Inc.
Veritas In Silico is a leading company in the field of mRNA drug discovery and development. With their innovative ibVIS platform, they are dedicated to achieving targeted drug design using mRNA technology. The company has a rich history of collaborations and partnerships with renowned pharmaceutical companies such as Takeda, Oncodesign Services, Rakuria Pharmaceuticals, and more.
Through these partnerships, Veritas In Silico aims to advance the development of low-molecular-weight drugs that target mRNA. Their expertise in mRNA analysis and computational science has garnered recognition and trust from the industry. Veritas In Silico's team, comprised of experienced scientists and researchers, consistently contributes to scientific publications and presents their research at prestigious conferences.
Based in Tokyo, Veritas In Silico is committed to pushing the boundaries of molecular-targeted drug discovery, utilizing cutting-edge technologies and strategic collaborations. Their mission is to revolutionize the healthcare industry and improve the lives of patients worldwide
Company type
Privately Held
Year founded
2016
Company size
11-50 employees
Related Brands
Tags
AI drug discovery
RNA-targeted small-molecule drug development
Nucleic acid medicines
Drug delivery systems
MRNA-targeting programs
